Incyte Reports 2018 Second Quarter Financial Results and Updates on Key Clinical Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Incyte Reports 2018 Second Quarter Financial Results and Updates on Key Clinical Programs

Incyte (INCY) PT Lowered to $72 at RBC Capital

August 1, 2018 8:50 AM EDT

RBC Capital lowered its price target on Incyte (NASDAQ: INCY) to $72.00 (from $74.00) while maintaining a Sector Perform rating.

... More

Incyte (INCY) Q2 Revenue Tops Views

July 31, 2018 7:13 AM EDT

Incyte (NASDAQ: INCY) reported Q2 EPS of $0.26, $0.09 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $521.52 million versus the consensus estimate of $473.78 million.

2018 Financial... More